YT Tai
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Oncology top 10%
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
Papers in
-
- Protein Degradation and Inhibitors 3
- Histone Deacetylase Inhibitors Research 3
- Signaling Pathways in Disease 2
- Cancer therapeutics and mechanisms 1
-
- Multiple Myeloma Research and Treatments 7
- Co-authors
- Teru Hideshima (8 shared papers)Oliver S. Thomas (1 shared paper)Benno Rattel (1 shared paper)Diann Blanset (1 shared paper)Paul J. Adam (1 shared paper)Susanne Hipp (1 shared paper)Matthias Friedrich (1 shared paper)Jochen Wahl (1 shared paper)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
YT Tai
10 papers receiving 537 citations
Peers
Comparison fields: 5 of 55
- Hematology 245
- Oncology 247
- Molecular Biology 366
- Immunology 90
- Radiology, Nuclear Medicine and Imaging 95
Countries citing papers authored by YT Tai
This map shows the geographic impact of YT Tai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by YT Tai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites YT Tai more than expected).
Fields of papers citing papers by YT Tai
This network shows the impact of papers produced by YT Tai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by YT Tai. The network helps show where YT Tai may publish in the future.
Co-authors
The 25 scholars most cited alongside YT Tai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 194 | |
| 2 | 2007 | 106 | |
| 3 | 2017 | 83 | |
| 4 | 2017 | 66 | |
| 5 | 2015 | 53 | |
| 6 | Insulin-like growth factor-1 induces adhesion and migration in human multiple myeloma cells via activation of b1-integrin and phosphatidylinositol 3-kinase/AKT signaling beta. | 2003 | 33 |
| 7 | LAQ824 is a novel histone deacetylase inhibitor with significant activity against multiple myeloma: Results of a pre-clinical evaluation in vitro and in vivo. | 2002 | 5 |
| 8 | Gene expression analysis of tumor cells sensitive and resistant to PS-341 (Bortezomib) treatment: Clinical implications. | 2003 | 1 |
| 9 | Critical role for Hck-mediated phosphorylation of Gab1 and Gab2 docking proteins in interleukin-6-induced proliferation and survival of multiple myeloma cells. | 2003 | 1 |
| 10 | beta-Lapachone is safe and effective in Biege-Nude-Xid mouse xenograft model of human plasmacytoma. | 2001 | 1 |
About YT Tai
YT Tai is a scholar working on Molecular Biology, Hematology, Oncology, Pathology and Forensic Medicine and Organic Chemistry, having authored 10 papers that have together received 543 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (7 papers), Protein Degradation and Inhibitors (3 papers), Histone Deacetylase Inhibitors Research (3 papers), Cancer Mechanisms and Therapy (3 papers), Peptidase Inhibition and Analysis (3 papers), Signaling Pathways in Disease (2 papers), Cancer therapeutics and mechanisms (1 paper) and Chronic Lymphocytic Leukemia Research (1 paper). The work is most often cited by research in Hematology (245 citations), Oncology (247 citations), Molecular Biology (366 citations), Immunology (90 citations) and Radiology, Nuclear Medicine and Imaging (95 citations). YT Tai has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Teru Hideshima, Oliver S. Thomas, Benno Rattel, Diann Blanset, Paul J. Adam, Susanne Hipp, Matthias Friedrich, Jochen Wahl, D Chauhan and Nikhil C. Munshi. Their work appears in journals such as Blood, Leukemia, Oncogene and Blood Cancer Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.